Opinion

Video

Heterogenous Presentation Of Atopic Dermatitis

Panelists discuss how the clinical heterogeneity of Atopic Dermatitis (AD) presents diagnostic challenges, with varying criteria for pediatric and adult-onset AD, highlighting the need for age-specific approaches to accurately diagnose and treat the condition.

Video content above is prompted by the following:

  • Please discuss the clinical heterogeneity of Atopic Dermatitis (AD). How well do the diagnostic criteria apply across patients of different ages?
  • Pediatric AD
  • Adult-onset AD
Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
4 experts are featured in this series.
4 experts are featured in this series.
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Related Content
Darren Brenner, MD | Credit: Northwestern Medicine
December 24th 2024

Tenapanor Improves Abdominal Symptoms Independent of Bowel Symptoms in IBS-C

Abigail Brooks, MA
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
December 16th 2024

Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Credit: Adobe Stock/ Onephoto
December 23rd 2024

Greater Non-HDL/HDL Cholesterol Ratio Linked to Lower Anemia Rates

Chelsie Derman
Irl Hirsch, MD | Credit: University of Washington
December 12th 2024

Diabetes Dialogue: Celebrating 25 Years of CGM, with Irl Hirsch, MD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA Logo | Credit: US Food and Drug Administration
December 23rd 2024

FDA Approves Generic Once-Daily GLP-1 RA for Type 2 Diabetes in Pediatric, Adult Patients

Patrick Campbell
FDA Approves Concizumab for Hemophilia A or B with Inhibitors | Image Credit: US Food and Drug Administration
December 23rd 2024

FDA Approves Concizumab for Hemophilia A or B with Inhibitors

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.